Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Aptevo Therapeutics ( (APVO) ) has shared an update.
On February 18, 2026, Aptevo Therapeutics Inc. held a special meeting of stockholders at which investors rejected technical and administrative amendments to the company’s Amended and Restated Certificate of Incorporation, reflecting insufficient support for proposed corporate governance changes. At the same meeting, stockholders approved the potential issuance of more than 19.99% of Aptevo’s outstanding common stock under its Standby Equity Purchase Agreement with Yorkville and authorized the option to adjourn the special meeting, moves that secure access to additional equity financing capacity and provide procedural flexibility for future corporate actions.
The most recent analyst rating on (APVO) stock is a Hold with a $6.50 price target. To see the full list of analyst forecasts on Aptevo Therapeutics stock, see the APVO Stock Forecast page.
Spark’s Take on APVO Stock
According to Spark, TipRanks’ AI Analyst, APVO is a Neutral.
The score is held down primarily by very weak financial performance (no revenue, large ongoing losses, and heavy cash burn) and a strong technical downtrend. Offsetting this somewhat are positive corporate events—extended financing runway and encouraging trial results—while valuation offers limited support due to the company’s loss-making profile.
To see Spark’s full report on APVO stock, click here.
More about Aptevo Therapeutics
Aptevo Therapeutics Inc. is a biopharmaceutical company focused on developing oncology and hematology therapeutics, leveraging its antibody-based platforms to create novel treatments for cancer and related diseases. The company targets specialized markets where innovative immunotherapies can address unmet medical needs and potentially improve patient outcomes.
Average Trading Volume: 186,331
Technical Sentiment Signal: Strong Sell
Current Market Cap: $7.13M
For detailed information about APVO stock, go to TipRanks’ Stock Analysis page.